| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/17/2002 | WO2002004505A1 A novel polypeptide - human semaphorin protein 9 and a polynucleotide encoding the same |
| 01/17/2002 | WO2002004504A1 A novel polypeptide - human g-protein subunit 9.46 and a polynucleotide encoding the same |
| 01/17/2002 | WO2002004503A1 A new polypeptide- human l1 factor orf2 reverse transcription-related protein 15 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004502A1 A NEW POLYPEPTIDE- MURINE ZINC FINGER PROTEIN (Zfp-1)16 AND THE POLYNUCLEOTIDE ENCODING IT |
| 01/17/2002 | WO2002004500A1 A new polypeptide- human zinc finger protein fpm315-17 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004498A1 A NOVEL POLYPEPTIDE - THE HUMAN ALPHA-2,3 SIALYLTRANSFERASE(ST3 Gal VI) 9.57 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 01/17/2002 | WO2002004496A2 Fimh adhesin proteins and methods of use |
| 01/17/2002 | WO2002004495A2 Streptococcus pyogenes antigen |
| 01/17/2002 | WO2002004493A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | WO2002004491A2 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004489A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/17/2002 | WO2002004488A2 Nucleic acid binding polypeptides |
| 01/17/2002 | WO2002004487A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 01/17/2002 | WO2002004482A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 01/17/2002 | WO2002004479A1 TRANSFORMING GROWTH FACTOR BETA (TGF-β) BLOCKING AGENT-TREATED STEM CELL COMPOSITION AND METHOD |
| 01/17/2002 | WO2002004027A1 Purification of plasmid dna by hydrophobic interaction chromatography |
| 01/17/2002 | WO2002004022A1 High fidelity polymerases and uses thereof |
| 01/17/2002 | WO2002004020A2 Pathogen resistance in organisms |
| 01/17/2002 | WO2002004007A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof |
| 01/17/2002 | WO2002004002A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 01/17/2002 | WO2002003911A2 Prevention and treatment of alzheimer's disease |
| 01/17/2002 | WO2002003849A2 Microarray method of genotyping multiple samples at multiple loci |
| 01/17/2002 | WO2002003812A2 Animal feed containing polypeptides |
| 01/17/2002 | WO2002003793A2 Transgenic mice containing targeted gene disruptions |
| 01/17/2002 | WO2002003792A2 Transgenic mice containing targeted protease inhibitor gene disruptions |
| 01/17/2002 | WO2002003791A2 Transgenic mice containing targeted gene disruptions |
| 01/17/2002 | WO2002003790A2 Transgenic mice containing targeted kinase gene disruptions |
| 01/17/2002 | WO2002003789A2 Transgenic mice containing targeted gpcr gene disruptions |
| 01/17/2002 | WO2002003788A2 Transgenic mice containing targeted phosphatase gene disruptions |
| 01/17/2002 | WO2002003787A2 Transgenic mice containing targeted gene disruptions |
| 01/17/2002 | WO2001079296B1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family |
| 01/17/2002 | WO2001072962A3 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/17/2002 | WO2001070981A3 Nucleic acids and polypeptides of invertebrate g-protein coupled receptors and methods of use |
| 01/17/2002 | WO2001062786A3 Tlp peptides and dna sequences coding the same |
| 01/17/2002 | WO2001061006A3 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 01/17/2002 | WO2001055370A3 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/17/2002 | WO2001055342A3 Synthetic genes for enhanced expression |
| 01/17/2002 | WO2001055299A3 Isolated polynucleotide encoding a novel phosphate transporter in plants and a method of modulating phosphate uptake in plants |
| 01/17/2002 | WO2001054672A3 Closure of bacterial ghosts |
| 01/17/2002 | WO2001054651A3 Modulation of gene expression in formation of fatty atherosclerotic lesions |
| 01/17/2002 | WO2001053474A3 Flavobacterium heparinum expression system |
| 01/17/2002 | WO2001051922A3 Identification of peripheral benzodiazepine receptor binding agents |
| 01/17/2002 | WO2001049838A3 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 01/17/2002 | WO2001049837A3 Process for the synthesis of vertebrate telomeric dna |
| 01/17/2002 | WO2001049106A3 Method for cloning animals with targetted genetic alterations |
| 01/17/2002 | WO2001048229A3 Conditional gene silencing in eukaryotes by promoter insertion |
| 01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 01/17/2002 | WO2001047543A3 Activation and inhibition of the immune system |
| 01/17/2002 | WO2001046228A3 Nucleic acid vaccination |
| 01/17/2002 | WO2001044448A3 Human oxidoreductase proteins |
| 01/17/2002 | WO2001044291A3 Polynucleotid encoding the rg1 polypeptide |
| 01/17/2002 | WO2001042502A3 Methods for disease detection |
| 01/17/2002 | WO2001042299A3 Hepatitis virus sentinel virus i (svi) |
| 01/17/2002 | WO2001042211A3 Detection of transmembrane potentials by optical methods |
| 01/17/2002 | WO2001040468A3 Molecules of the card-related protein family and uses thereof |
| 01/17/2002 | WO2001040455A3 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 01/17/2002 | WO2001040312A3 Naive screening method |
| 01/17/2002 | WO2001040272A3 In situ bioreactors and methods of use thereof |
| 01/17/2002 | WO2001036682A3 Long oligonucleotide arrays |
| 01/17/2002 | WO2001036619A3 Cloning and characterization of the cap gene promoter |
| 01/17/2002 | WO2001036596A3 Modulation of plant response to abscisic acid |
| 01/17/2002 | WO2001034846A3 Direct mapping of dna chips to detector arrays |
| 01/17/2002 | WO2001034833A3 Regulating endogenous inhibitor at atp synthase |
| 01/17/2002 | WO2001034820A3 Chemical inducible promoters used to obtain transgenic plants with a silent marker |
| 01/17/2002 | WO2001034819A3 Genes and methods for manipulation of growth |
| 01/17/2002 | WO2001034818A3 Sorghum dwarfing genes and methods of use |
| 01/17/2002 | WO2001034817A3 Genes encoding enzymes for lignin biosynthesis and uses thereof |
| 01/17/2002 | WO2001034803A3 Crib protein zmse1 |
| 01/17/2002 | WO2001034769A3 24 human secreted proteins |
| 01/17/2002 | WO2001034091A3 Modification of polysaccharide containing materials |
| 01/17/2002 | WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 01/17/2002 | WO2001032838A3 Methods for improving viral vector titers and reducing cell death in cell cultures |
| 01/17/2002 | WO2001032706A3 Novel human transporter proteins and polynucleotides encoding the same |
| 01/17/2002 | WO2001032696A3 Traf family proteins |
| 01/17/2002 | WO2001031051A3 Antisense modulation of protein kinase c-theta expression |
| 01/17/2002 | WO2001031011A3 Gene mining system and method |
| 01/17/2002 | WO2001030362A3 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 01/17/2002 | WO2001029230A3 Engineering disease resistance with pectate lyase-like genes |
| 01/17/2002 | WO2001029078A3 Method for production and use of mite group 1 proteins |
| 01/17/2002 | WO2001029072A3 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 01/17/2002 | WO2001027317A3 Method for distinguishing 5-position methylation changes |
| 01/17/2002 | WO2001027298A3 Sclerotinia-inducible genes and promoters and their uses |
| 01/17/2002 | WO2001027290A3 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 01/17/2002 | WO2001027144A3 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 01/17/2002 | WO2001025429A3 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 01/17/2002 | WO2001023589A3 23431, a novel human ubiquitin protease |
| 01/17/2002 | WO2001023541A3 Compositions and methods for altering gene expression |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | WO2001021821A3 Insect-resistant rice plants |
| 01/17/2002 | WO2001021310A3 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification |
| 01/17/2002 | WO2001020010A3 Transcriptionally silenced plant genes |
| 01/17/2002 | WO2001016377A3 Diagnostics and therapeutics for osteoporosis |
| 01/17/2002 | WO2001016366A3 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks |
| 01/17/2002 | WO2001016308A3 Plant sterol acyltransferases |
| 01/17/2002 | WO2001016293A3 Dna encoding the human serine protease t |
| 01/17/2002 | WO2001016174A3 Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopes of mycobacterial heat shock protein 65 |
| 01/17/2002 | WO2001013117A3 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 01/17/2002 | WO2001012829A3 Replication deficient baculovirus expression system |
| 01/17/2002 | WO2001011033A3 Identification of genes essential for the survival of haemophilus influenzae through genome scanning by transposition mutagenesis |